Nanostructured lipid carriers (NLCs) versus solid lipid nanoparticles (SLNs) for topical delivery of meloxicam | Ahmed Abdelbary

Nanostructured lipid carriers (NLCs) versus solid lipid nanoparticles (SLNs) for topical delivery of meloxicam

Citation:: Khalil, R. M., A. Abd-Elbary, M. A. Kassem, M. M. Ghorab, and M. Basha, "Nanostructured lipid carriers (NLCs) versus solid lipid nanoparticles (SLNs) for topical delivery of meloxicam", Pharm Dev Technol, vol. 19, issue 3, pp. 304-314, 2014.